Clinical trial IJB-MULTI-MIME-A-2017
IJB-MULTI-MIME-A-2017 Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trial
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Oui |
Sponsor | Institut Jules Bordet |
EudraCT Identifier | 2017-000123-28 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03339843 |
Inclusion criteria | Metastatic or non-resecable. Refractory to platinum regimen |
Last update |